GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Samsung Biologics Co 207940.KS · KRW

Health Care · Life Sciences Tools & Services · KRX · 🇰🇷 South Korea

Compare

1,510,000

-0.40%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Samsung Biologics Co — daily KRX:207940

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Samsung Biologics Co on TradingView ↗
Market value
₩69.90trn
Last close × shares
Volume
67.9k
Shares, 9 Nov 2026
Price to earnings
41.7

About Samsung Biologics Co

Its shares trade on KRX under the ticker 207940.KS. It has been listed since 10 November 2016. In the fiscal year to 31 December 2025, it reported revenue of ₩4.56trn and net income of ₩1.78trn. At that date it held total assets of ₩11.06trn and shareholders' equity of ₩7.45trn.

SAMSUNG BIOLOGICS Co., Ltd. engages in the provision of contract manufacturing organization services for pharmaceutical products. The company is headquartered in Incheon, Incheon. The company went IPO on 2016-11-10. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. The company also provides cell line development and process development services. The firm distributes its products in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

More about Samsung Biologics Co →

Latest on Samsung Biologics Co

Our reporting

Next results

27 Jan 2027

Due on 27 Jan 2027. Analysts expect earnings of 11137.25 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Samsung Biologics Co's ticker?

Samsung Biologics Co trades as 207940.KS on KRX, under ISIN KR7207940008.

What was Samsung Biologics Co's last closing price?

1,510,000 on 9 Nov 2026. The figure is in KRW and is never converted.

When does Samsung Biologics Co next report results?

Results are expected on 27 Jan 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.